Literature DB >> 4119739

D(-)penicillamine in morphoea (localised scleroderma).

E J Moynahan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4119739     DOI： 10.1016/s0140-6736(73)90287-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  D-penicillamine in dermatology: influence on enzymatic activities of human skin in vitro.

Authors:  W Raab; B Gmeiner
Journal:  Arch Dermatol Res       Date:  1975-11-14       Impact factor: 3.017

2.  Penicillamine in the treatment of rheumatoid arthritis.

Authors:  A V Camp
Journal:  Proc R Soc Med       Date:  1977-02

Review 3.  Systemic and localized scleroderma in children: current and future treatment options.

Authors:  Margalit E Rosenkranz; Lucila M A Agle; Petros Efthimiou; Thomas J A Lehman
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 4.  D-Penicillamine: The State of the Art in Humans and in Dogs from a Pharmacological and Regulatory Perspective.

Authors:  Michela Pugliese; Vito Biondi; Enrico Gugliandolo; Patrizia Licata; Alessio Filippo Peritore; Rosalia Crupi; Annamaria Passantino
Journal:  Antibiotics (Basel)       Date:  2021-05-28

5.  Historical perspectives on penicillamine.

Authors:  L Fernandes; H Berry; E Hamilton
Journal:  J R Coll Physicians Lond       Date:  1980-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.